pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • M-701
    no indication Wuhan YZY Biopharma Co Ltd1 cat
  • MK-6050
    no indication$MRK Merck & Co., Inc.1 cat
  • MK-8748
    no indication Eyebiotech Ltd1 cat
  • MKK-900
    no indication MAXVAX Biotechnology Co Ltd1 cat
← prev
page 4 of 231
next →
Pain89
Neurology1
  • MT-026
    no indication Jiangsu Maoxing Technology Co Ltd1 cat
  • Phase 2
    ONO-4578
    Metastatic Colorectal Cancer Bristol-Myers Squibb Co1 cat
  • ORX-750
    no indication Celerion Inc1 cat
  • PEP-CMV
    no indication National Cancer Institute US1 cat
  • PST-611
    no indication Ilife Consulting Sarl1 cat
  • QLS-5212
    no indication Qilu Pharmaceutical Co Ltd1 cat
  • RC-288
    no indication RemeGen Co Ltd1 cat
  • RPG-102
    no indication$RANI Rani Therapeutics Holdings, Inc.1 cat
  • SIBPA-13
    no indication Shanghai Institute of Biological Products Co Ltd1 cat
  • SKB-103
    no indication Sichuan Kelun Pharmaceutical Co Ltd1 cat
  • SSJG-009
    no indication Sunstar Inc1 cat
  • SynPro-15G
    no indication National Cheng-Kung University Hospital1 cat
  • UA-021
    no indication Usynova Pharmaceuticals Ltd1 cat
  • VC-005
    no indication Jiangsu Vcare PharmaTech Co Ltd1 cat
  • VX-993
    no indication$VERX Vertex, Inc.1 cat
  • Vacucis
    no indication Instituto de Investigacion sanitaria de Santiago de Compostela1 cat
  • XC-243
    no indication Pharmenterprises1 cat
  • XS-411
    no indication Beijing Tiantan Hospital1 cat
  • ZE-740282
    no indication Avance Clinical Pty Ltd1 cat
  • afamelanotide
    no indication Centre International de Développement Pharmaceutique1 cat
  • alfentanil
    no indication Taian City Central Hospital1 cat
  • Marketed
    apixaban ODT
    Eliquis (apixaban)
    Venous Thromboembolism Bristol-Myers Squibb Co1 cat
  • aumolertinib mesylate
    no indication Guangzhou Panyu Central Hospital1 cat
  • autologous platelet rich plasma
    no indication Affiliated Stomatological Hospital of Guangxi Medical University1 cat
  • autologous regulatory T cells
    no indication Guy's and St Thomas' NHS Foundation Trust1 cat
  • Marketed
    avelumab
    Bavencio (avelumab)
    Merkel Cell Carcinoma EMD Serono Inc1 cat